TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
Download Report PDF Instantly
Report overview
The global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market was valued at US$ million in 2022 and is projected to reach US$ million by 2035, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and kidney disease.
This report aims to provide a comprehensive presentation of the global market for Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nonsteroidal Anti-Inflammatory Drugs (NSAIDs). This report contains market size and forecasts of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in global, including the following market information:
Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue, 2018-2023, 2024-2035, ($ millions)
Global top five companies in 2022 (%)
North America dominated the global NSAID API market due to high demand for APIs in drug formulations and research and development programs in this region. The region is expected to continue its dominance in the coming years owing to increasing preference for generic medicines as a result of high healthcare costs in the U.S. Among other regions, Asia-Pacific is the next largest market for APIs. This region has become the most attractive market due to clustering of a large number of generic medicine manufacturers.
We surveyed the Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), market overview.
Chapter 2: Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market size in revenue.
Chapter 3: Detailed analysis of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
